| Product Code: ETC13335027 | Publication Date: Apr 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | No. of Pages: 150 | No. of Figures: 55 | No. of Tables: 32 |
Africa Non-Alcoholic Steatohepatitis Market |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Africa Non-Alcoholic Steatohepatitis Market Overview |
3.1 Africa Regional Macro Economic Indicators |
3.2 Africa Non-Alcoholic Steatohepatitis Market Revenues & Volume, 2021 & 2031F |
3.3 Africa Non-Alcoholic Steatohepatitis Market - Industry Life Cycle |
3.4 Africa Non-Alcoholic Steatohepatitis Market - Porter's Five Forces |
3.5 Africa Non-Alcoholic Steatohepatitis Market Revenues & Volume Share, By Countries, 2021 & 2031F |
3.6 Africa Non-Alcoholic Steatohepatitis Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.7 Africa Non-Alcoholic Steatohepatitis Market Revenues & Volume Share, By Drug Class, 2021 & 2031F |
3.8 Africa Non-Alcoholic Steatohepatitis Market Revenues & Volume Share, By Mechanism of Action, 2021 & 2031F |
3.9 Africa Non-Alcoholic Steatohepatitis Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.10 Africa Non-Alcoholic Steatohepatitis Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 Africa Non-Alcoholic Steatohepatitis Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Africa Non-Alcoholic Steatohepatitis Market Trends |
6 Africa Non-Alcoholic Steatohepatitis Market, 2021 - 2031 |
6.1 Africa Non-Alcoholic Steatohepatitis Market, Revenues & Volume, By Type, 2021 - 2031 |
6.1.1 Overview & Analysis |
6.1.2 Africa Non-Alcoholic Steatohepatitis Market, Revenues & Volume, By Primary NASH, 2021 - 2031 |
6.1.3 Africa Non-Alcoholic Steatohepatitis Market, Revenues & Volume, By Secondary NASH, 2021 - 2031 |
6.2 Africa Non-Alcoholic Steatohepatitis Market, Revenues & Volume, By Drug Class, 2021 - 2031 |
6.2.1 Overview & Analysis |
6.2.2 Africa Non-Alcoholic Steatohepatitis Market, Revenues & Volume, By Farnesoid X Receptor (FXR) Agonists, 2021 - 2031 |
6.2.3 Africa Non-Alcoholic Steatohepatitis Market, Revenues & Volume, By Acetyl-CoA Carboxylase (ACC) Inhibitors, 2021 - 2031 |
6.2.4 Africa Non-Alcoholic Steatohepatitis Market, Revenues & Volume, By Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists, 2021 - 2031 |
6.2.5 Africa Non-Alcoholic Steatohepatitis Market, Revenues & Volume, By Peroxisome Proliferator-Activated Receptor (PPAR) Agonists, 2021 - 2031 |
6.3 Africa Non-Alcoholic Steatohepatitis Market, Revenues & Volume, By Mechanism of Action, 2021 - 2031 |
6.3.1 Overview & Analysis |
6.3.2 Africa Non-Alcoholic Steatohepatitis Market, Revenues & Volume, By Anti-Inflammatory, 2021 - 2031 |
6.3.3 Africa Non-Alcoholic Steatohepatitis Market, Revenues & Volume, By Anti-Fibrotic, 2021 - 2031 |
6.3.4 Africa Non-Alcoholic Steatohepatitis Market, Revenues & Volume, By Metabolic Modifiers, 2021 - 2031 |
6.4 Africa Non-Alcoholic Steatohepatitis Market, Revenues & Volume, By Route of Administration, 2021 - 2031 |
6.4.1 Overview & Analysis |
6.4.2 Africa Non-Alcoholic Steatohepatitis Market, Revenues & Volume, By Oral, 2021 - 2031 |
6.4.3 Africa Non-Alcoholic Steatohepatitis Market, Revenues & Volume, By Injectable, 2021 - 2031 |
6.5 Africa Non-Alcoholic Steatohepatitis Market, Revenues & Volume, By End User, 2020 - 2028 |
6.5.1 Overview & Analysis |
6.5.2 Africa Non-Alcoholic Steatohepatitis Market, Revenues & Volume, By Hospitals, 2020 - 2028 |
6.5.3 Africa Non-Alcoholic Steatohepatitis Market, Revenues & Volume, By Clinics, 2020 - 2028 |
6.5.4 Africa Non-Alcoholic Steatohepatitis Market, Revenues & Volume, By Research Institutes, 2020 - 2028 |
7 Africa Non-Alcoholic Steatohepatitis Market, By Countries, 2021 - 2031 |
7.1 Overview & Analysis |
7.2 Africa Non-Alcoholic Steatohepatitis Market, Revenues & Volume, By Type, 2021 - 2031 |
7.2.1 South Africa Non-Alcoholic Steatohepatitis Market, Revenues & Volume, By Type, 2021 - 2031 |
7.2.2 Egypt Non-Alcoholic Steatohepatitis Market, Revenues & Volume, By Type, 2021 - 2031 |
7.2.3 Nigeria Non-Alcoholic Steatohepatitis Market, Revenues & Volume, By Type, 2021 - 2031 |
7.2.4 Rest of Africa Non-Alcoholic Steatohepatitis Market, Revenues & Volume, By Type, 2021 - 2031 |
7.3 Africa Non-Alcoholic Steatohepatitis Market Revenues & Volume Share, By Drug Class, 2021 & 2031F |
7.3.1 South Africa Non-Alcoholic Steatohepatitis Market, Revenues & Volume, By Drug Class, 2021 - 2031 |
7.3.2 Egypt Non-Alcoholic Steatohepatitis Market, Revenues & Volume, By Drug Class, 2021 - 2031 |
7.3.3 Nigeria Non-Alcoholic Steatohepatitis Market, Revenues & Volume, By Drug Class, 2021 - 2031 |
7.3.4 Rest of Africa Non-Alcoholic Steatohepatitis Market, Revenues & Volume, By Drug Class, 2021 - 2031 |
7.4 Africa Non-Alcoholic Steatohepatitis Market, Revenues & Volume, By Mechanism of Action, 2021 - 2031 |
7.4.1 South Africa Non-Alcoholic Steatohepatitis Market, Revenues & Volume, By Mechanism of Action, 2021 - 2031 |
7.4.2 Egypt Non-Alcoholic Steatohepatitis Market, Revenues & Volume, By Mechanism of Action, 2021 - 2031 |
7.4.3 Nigeria Non-Alcoholic Steatohepatitis Market, Revenues & Volume, By Mechanism of Action, 2021 - 2031 |
7.4.4 Rest of Africa Non-Alcoholic Steatohepatitis Market, Revenues & Volume, By Mechanism of Action, 2021 - 2031 |
7.5 Africa Non-Alcoholic Steatohepatitis Market, Revenues & Volume, By Route of Administration, 2021 - 2031 |
7.5.1 South Africa Non-Alcoholic Steatohepatitis Market, Revenues & Volume, By Route of Administration, 2021 - 2031 |
7.5.2 Egypt Non-Alcoholic Steatohepatitis Market, Revenues & Volume, By Route of Administration, 2021 - 2031 |
7.5.3 Nigeria Non-Alcoholic Steatohepatitis Market, Revenues & Volume, By Route of Administration, 2021 - 2031 |
7.5.4 Rest of Africa Non-Alcoholic Steatohepatitis Market, Revenues & Volume, By Route of Administration, 2021 - 2031 |
7.6 Africa Non-Alcoholic Steatohepatitis Market, Revenues & Volume, By End User, 2021 - 2031 |
7.6.1 South Africa Non-Alcoholic Steatohepatitis Market, Revenues & Volume, By End User, 2021 - 2031 |
7.6.2 Egypt Non-Alcoholic Steatohepatitis Market, Revenues & Volume, By End User, 2021 - 2031 |
7.6.3 Nigeria Non-Alcoholic Steatohepatitis Market, Revenues & Volume, By End User, 2021 - 2031 |
7.6.4 Rest of Africa Non-Alcoholic Steatohepatitis Market, Revenues & Volume, By End User, 2021 - 2031 |
8 Africa Non-Alcoholic Steatohepatitis Market Key Performance Indicators |
9 Africa Non-Alcoholic Steatohepatitis Market - Export/Import By Countries Assessment |
10 Africa Non-Alcoholic Steatohepatitis Market - Opportunity Assessment |
10.1 Africa Non-Alcoholic Steatohepatitis Market Opportunity Assessment, By Countries, 2021 & 2031F |
10.2 Africa Non-Alcoholic Steatohepatitis Market Opportunity Assessment, By Type, 2021 & 2031F |
10.3 Africa Non-Alcoholic Steatohepatitis Market Opportunity Assessment, By Drug Class, 2021 & 2031F |
10.4 Africa Non-Alcoholic Steatohepatitis Market Opportunity Assessment, By Mechanism of Action, 2021 & 2031F |
10.5 Africa Non-Alcoholic Steatohepatitis Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
10.6 Africa Non-Alcoholic Steatohepatitis Market Opportunity Assessment, By End User, 2021 & 2031F |
11 Africa Non-Alcoholic Steatohepatitis Market - Competitive Landscape |
11.1 Africa Non-Alcoholic Steatohepatitis Market Revenue Share, By Companies, 2022 |
11.2 Africa Non-Alcoholic Steatohepatitis Market Competitive Benchmarking, By Operating and Technical Parameters |
12 Top 10 Company Profiles |
13 Recommendations |
14 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here